Landmark HIV treatment-as-prevention study shows additional health benefits, cost-effectiveness
WHAT: Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays ...
Jul 27, 2012
0
0